Status:
COMPLETED
A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
Lead Sponsor:
Yonsei University
Conditions:
Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the benefits in the atrial fibrillation detection rate of the continuous ECG monitoring group for more than 8 days by contrasting with one-day ECG monitoring u...
Eligibility Criteria
Inclusion
- \[Inclusion criteria\]
- A participant will be eligible for inclusion in the study if the participant:
- Has provided documented informed consent for the study.
- Is adult at least 19 years of age on the day of providing documented informed consent
- Is the high risk group for stroke, i.e. adult at least 75 years of age or CHA2DS2-VASc score more than 2
- Is life expectancy more than 6 months
- Has no Atrial fibrillation or Atrial flutter as a result of 12-lead ECG
- Has symptoms associated with Atrial fibrillation \*symptoms associated with Atrial fibrillation: palpitation, dizziness, dyspnea, syncope, stroke/transient ischemic accident, systemic embolism etc.
- \[Exclusion criteria\]
- The participant must be excluded from the study if the participant:
- Has had prior history of Atrial fibrillation or Atrial flutter
- Has received prior or ongoing anticoagulant or antiplatelet therapy
- Has inserted Pacemaker or Defibrillator that can diagnose Atrial fibrillation or Atrial flutter
- Has plan of Carotid endarterectomy or inserting Stent\* within 90 days on the day of providing document informed consent \*Stent insertion: means when stent-related interventions have been performed on the carotid arteyr or coronary arteries.
Exclusion
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05355948
Start Date
May 9 2022
End Date
July 31 2024
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea